Sample 154

Evaluation Instructions

Important: Models were tasked with extracting evidence from documents. Some outputs may be low quality and should be scored accordingly.

Your task: Compare the model-generated prediction (right panel) against the ground truth criteria (left panel).

Clean view: Shows formatted, readable text for easy comparison
Diff view: Highlights differences between ground truth and prediction
Raw view: Shows original unformatted text as it appears in the dataset

Evaluation scale (0-4):

0 = No match: Prediction is unrelated or contradicts the target criteria
1 = Poor match: Minimal overlap with ground truth, major errors or omissions
2 = Partial match: Some key elements captured, but notable gaps or inaccuracies
3 = Good match: Most elements correct, minor differences or formatting issues
4 = Excellent match: Essentially identical content, fully correct capture

Consider both content accuracy and completeness. Some predictions may be technically "correct" but incomplete or out of order.

Ground Truth

INCLUSION CRITERIA

  1. Aged 12 to <18 years
  2. Parent or legal guardian must provide written informed consent
  3. Treatment naïve or experienced children with genotype 1 or 4 HCV infection, and are on a maintenance cancer chemotherapy regimen
  4. Receiving a protocol-approved maintenance chemotherapy regimen for a hematological malignancy
  5. Chronic HCV infection (≥ 6 months) documented by medical history or liver biopsy
  6. Screening laboratory values within defined thresholdsNo History of solid organ or bone marrow transplantationNo history of clinical hepatic decompensation (eg, ascites, jaundice, encephalopathy, variceal hemorrhage)NOTE: Other protocol defined Inclusion/

EXCLUSION CRITERIA

  1. may apply.

Prediction

Amended Eligibility Criteria (version 2):

INCLUSION CRITERIA

  1. Aged 12 to <18 years
  2. Parent or legal guardian must provide written informed consent
  3. Treatment naïve or experienced children with genotype 1 or 4 HCV infection, and are on a maintenance cancer chemotherapy regimen
  4. Receiving a protocol-approved maintenance chemotherapy regimen for a hematological malignancy
  5. Chronic HCV infection (≥ 6 months) documented by medical history or liver biopsy
  6. Screening laboratory values within defined thresholds, including:
  7. Hemoglobin ≥ 8 g/dL
  8. Absolute Neutrophil Count (ANC) ≥ 1,000/mm³
  9. Platelets ≥ 50,000/mm³
  10. ALT ≤ 5 x upper limit of normal (ULN)
  11. Direct bilirubin ≤ 1.5 x baseline
  12. No history of solid organ or bone marrow transplantation
  13. No history of clinical hepatic decompensation (e.g., ascites, jaundice, encephalopathy, variceal hemorrhage)
  14. Female subjects of childbearing potential must have a negative serum pregnancy test at screening and agree to use effective contraception during the study and for 30 days after the last dose of study drug.